Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Discovery Research In Japan By Global Pharmaceutical Outfits: Evolving More Toward Partnerships? (Part 1 of 3)

This article was originally published in PharmAsia News

Executive Summary

Several multinational pharmaceutical companies have shut down their Japan-based discovery research facilities over the last few years. Some, instead, are relying more on partnerships with local drug research entities in Japan. PharmAsia News' Tokyo bureau examines the factors behind the trend in this first article in a three-part series on the subject.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072152

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel